Heron Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
50%
€1.12
Target price
31.03.26
€2.30
Performance (%)
51.79%
End price
08.01.24
€1.70
Summary
This prediction ended on 08.01.24 with a price of €1.70. With a performance of 51.79% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Heron Therapeutics Inc. where he still thinks Heron Therapeutics Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Heron Therapeutics Inc. | 3.643% | 3.643% | 102.766% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
According to BiotechBee what are the pros and cons of Heron Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Heron Therapeutics Inc. diskutieren
Buy mit Kursziel 2,3
In the thread Trading Heron Therapeutics Inc.
Buy beendet
Current prediction by BiotechBee for Heron Therapeutics Inc.
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.70
08.01.24
08.01.24
€3.00
30.09.25
30.09.25
12.12%
02.10.24
02.10.24
Could be very worthwhile Investment >20% year